Recurrent and/or Metastatic Platinum-refractory SCCHN
1 clinical trials · Condition
◉ Watch Recurrent and/or Metastatic Platinum-refractory SCCHN
| Record | Firm | Date |
|---|---|---|
| Nivolumab in Recurrent and/or Metastatic SCCHN (NCT03226756) | UNICANCER | 2017-07-07 |
Track Recurrent and/or Metastatic Platinum-refractory SCCHN automatically
Every clearance here is in the API, with alerts when new ones post.